Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.29B.
ENTERPRISE VALUE (EV)
$3.29B
Acadia Pharmaceuticals Inc.
Market Cap
$3.45B
Enterprise Value (EV)
$3.29B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Acadia Pharmaceuticals Inc. (ACAD) | $3.45B | $3.29B |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.58B | $4.07B |
| Celcuity Inc. (CELC)vs › | $3.59B | $4.16B |
| CareDx, Inc (CDNA)vs › | $3.61B | $3.26B |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.62B | $3.38B |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.25B | $3.11B |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | $2.99B |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | $3.23B |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | $3.04B |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | $2.23B |
Market Cap
$3.45B
Total Debt
$11.63M
Cash
$177.69M
Enterprise Value
$3.29B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
